BlackRock Capital Allocation Term Trust (NYSE:BCAT – Get Free Report) was the target of a large decrease in short interest during the month of February. As of February 27th, there was short interest totaling 877,039 shares, a decrease of 12.3% from the February 12th total of 1,000,614 shares. Currently, 0.8% of the shares of the stock are sold short. Based on an average trading volume of 598,248 shares, the short-interest ratio is currently 1.5 days. Based on an average trading volume of 598,248 shares, the short-interest ratio is currently 1.5 days. Currently, 0.8% of the shares of the stock are sold short.
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in BCAT. TD Capital Management LLC lifted its position in BlackRock Capital Allocation Term Trust by 5.6% during the 4th quarter. TD Capital Management LLC now owns 33,812 shares of the company’s stock worth $479,000 after buying an additional 1,805 shares in the last quarter. NewEdge Advisors LLC increased its position in BlackRock Capital Allocation Term Trust by 4.7% in the 4th quarter. NewEdge Advisors LLC now owns 16,859 shares of the company’s stock valued at $239,000 after acquiring an additional 759 shares in the last quarter. XTX Topco Ltd acquired a new stake in BlackRock Capital Allocation Term Trust in the 4th quarter valued at about $368,000. Readystate Asset Management LP bought a new position in shares of BlackRock Capital Allocation Term Trust in the fourth quarter worth about $2,887,000. Finally, Rivernorth Capital Management LLC bought a new position in shares of BlackRock Capital Allocation Term Trust in the fourth quarter worth about $19,940,000. 36.12% of the stock is owned by institutional investors.
BlackRock Capital Allocation Term Trust Stock Up 0.3%
BCAT stock opened at $14.67 on Tuesday. The business has a fifty day moving average price of $14.84 and a 200 day moving average price of $14.67. BlackRock Capital Allocation Term Trust has a fifty-two week low of $12.91 and a fifty-two week high of $15.41.
BlackRock Capital Allocation Term Trust Dividend Announcement
About BlackRock Capital Allocation Term Trust
BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.
BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.
See Also
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
